Market Access/ Views & Analysis/ Views and analysis A problem combination? Leela Barham combination therapies, NHS, NICE 0 Comment Leela Barham takes stock of past NICE decisions for combinations to explore the scale of the reimbursement challenge Share X A problem combination? https://pharmaphorum.com/views-and-analysis/a-problem-combination/
Oncology/ Partner Content/ Partner content/ Press releases/ Quintiles-oncol-PC When science and biology combine – the outlook for ADCs in cancer drug development Adam Jeffery adc, antibody, cancer, combination therapies, haemato-oncology, Haematology, IQVIA, Oncology 0 Comment Antibody Drug Conjugates (ADCs) are treatments formed by the conjugation of monoclonal antibodies and cytotoxic agents. Although just Share X When science and biology combine – the outlook for ADCs in cancer drug development https://pharmaphorum.com/partner-content-oncology/science-biology-combine-outlook-adcs-cancer-drug-development/
